| Name | 5'-Deoxy-5-fluorocytidine |
|---|---|
| Synonyms |
Capecitabine Related Compound A (5''-deoxy-5-fluorocytidine)
5-Fluoro-5'-deoxycytidine 5-Deoxy-5-fluoroucytidineQ: What is 5-Deoxy-5-fluoroucytidine Q: What is the CAS Number of 5-Deoxy-5-fluoroucytidine Q: What is the storage condition of 5-Deoxy-5-fluoroucytidine Q: What e the applications of 5-Deoxy-5-fluoroucytidine 5-DFCR-D2 (Deoxy-5-fluorocytidine-d2) 5-Fluoro-5’-deoxycytidine, 5’-DFCR Capecitabine Imp.A Capecitabine Impurity A(Capecitabine Related Compound A) Capacitabine Related Compound A 5'-deoxy-5-fluoro-Cytidine Deoxy-5-fluorocytidine-D2 Capecitabine Impurity 1 Capecitabine RC A Capecitabine Impurity A/ Capecitabine Related Compund A 5'-DFCR 5'-DFCR (5'-Deoxy-5-fluorocytidine) 5-F-5'-dC Capecitabine Impurity A (5'-DFCR) Cytidine, 5'-deoxy-5-fluoro CAPECITABINE related substance A Capecitabine Impurity A 5’-Deoxy-5-fluorocytidine,Capecitabine related compound A Capecitabine Related Compound A Capecitabine Related Compound A (10 mg) (5'-deoxy-5-fluorocytidine) 5'-Deoxy-5-fluorocytidine> 5'-Deoxy-5-fluorocytidine //BP 5-DFCR (Deoxy-5-fluorocytidine) Deoxy fluorocytidine 4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoropyrimidin-2(1H)-one (Capecitabine Impurity) 4-Amino-1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-one (5'-Deoxy-5-fluorocytidine) 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-Methyltetrahydrofuran-2-yl)-5-fluoropyriMidin-2(1H)-one 5''-DEOXY-5-FLUOROCYTIDINE (5''-DFCR) 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-Methyloxolan-2-yl]-5-fluoro-1,2-dihydropyriMidin-2-one MFCD07369278 5'-Deoxy-5-fluoro-D-cytidine [2H2]-5-DFCR 4-Amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydro-2-furanyl]-5-fluoro-2(1H)-pyrimidinone 5'-Deoxy-5-fluorocytidin 5'-Deoxy-5-fluoro Cytidine Capecitabine Impurity A RC A) Capecitabine-1 |
| Description | 5-Fluoro-5'-deoxycytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 437.9±55.0 °C at 760 mmHg |
| Melting Point | 196-198ºC |
| Molecular Formula | C9H12FN3O4 |
| Molecular Weight | 245.21 |
| Flash Point | 218.6±31.5 °C |
| Exact Mass | 245.081177 |
| PSA | 110.60000 |
| LogP | -0.94 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.700 |
| Storage condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| Hazard Codes | Xn: Harmful;Xi: Irritant; |
|---|---|
| Risk Phrases | R20/21/22 |
| Safety Phrases | 26-36-37/39 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2934999090 |
|
~92%
66335-38-4 |
| Literature: ANGIOGENE PHARMACEUTICALS LIMITED; THE GRAY LABORATORY CANCER RESEARCH TRUST Patent: WO2006/32921 A1, 2006 ; Location in patent: Page/Page column 37-38 ; |
|
~95%
66335-38-4 |
| Literature: MacDonald, Peter Lindsay; Rossetto, Pierluigi; Gallina, Maurizio Patent: US2009/209754 A1, 2009 ; Location in patent: Page/Page column 9-10 ; |
|
~86%
66335-38-4 |
| Literature: Procopio, Antonio; Gaspari, Marco; Nardi, Monica; Oliverio, Manuela; Romeo, Roberto Tetrahedron Letters, 2008 , vol. 49, # 12 p. 1961 - 1964 |
|
~%
66335-38-4 |
| Literature: Chinese Chemical Letters, , vol. 21, # 2 p. 163 - 166 |
|
~%
66335-38-4
Detail
|
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 40, # 9 p. 2568 - 2571 |
| Precursor 4 | |
|---|---|
| DownStream 2 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |